Preemptive donor apoptotic cell infusions induce IFN-γ-producing myeloid-derived suppressor cells for cardiac allograft protection

Journal of Immunology

Volumn 192, Issue 12, 2014, Pages 6092-6101

  Bryant, Jane ^a   Lerret, Nadine M ^a   Wang, Jiao Jing ^b   Kang, Hee Kap ^a   Tasch, James ^a   Zhang, Zheng ^b   Luo, Xunrong ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC GRAFT REJECTION; CD11B+ GR1+ T CELL; CD11B+ LY6C+ T CELL; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME MECHANISM; IDO GENE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NOS2 GENE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL;

ALLOGRAFTS; ANIMALS; APOPTOSIS; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED BALB C; MYELOID CELLS; SPLEEN;

EID: 84902185123     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302771     Document Type: Article

References (47)

1. Sayegh, M. H., and C. B. Carpenter. 2004. Transplantation 50 years later-progress, challenges, and promises. N. Engl. J. Med. 351:2761-2766.
2. Luo, X., K. L. Pothoven, D. McCarthy, M. De Gutes, A. Martin, D. R. Getts, G. Xia, J. He, X. Zhang, D. B. Kaufman, and S. D. Miller. 2008. ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proc. Natl. Acad. Sci. USA 105:14527-14532.
3. Kheradmand, T., S. Wang, J. Bryant, J. J. Tasch, N. Lerret, K. L. Pothoven, J. L. Houlihan, S. D. Miller, Z. J. Zhang, and X. Luo. 2012. Ethylenecarbodiimidefixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance. J. Immunol. 189:804-812.
4. Kheradmand, T., S. Wang, R. F. Gibly, X. Zhang, S. Holland, J. Tasch, J. G. Graham, D. B. Kaufman, S. D. Miller, L. D. Shea, and X. Luo. 2011. Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. Biomaterials 32:4517-4524.
5. Wang, S., J. Tasch, T. Kheradmand, J. Ulaszek, S. Ely, X. Zhang, B. J. Hering, S. D. Miller, and X. Luo. 2013. Transient B-cell depletion combined with apoptotic donor splenocytes induces xeno-specific T- and B-cell tolerance to islet xenografts. Diabetes 62:3143-3150.
6. Lutterotti, A., S. Yousef, A. Sputtek, K. H. Sturner, J. P. Stellmann, P. Breiden, S. Reinhardt, C. Schulze, M. Bester, C. Heesen, et al. 2013. Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Sci. Transl. Med. 5:188ra175.
7. Turley, D. M., and S. D. Miller. 2007. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis. J. Immunol. 178:2212-2220.
8. Chen, G., T. Kheradmand, J. Bryant, S. Wang, J. Tasch, J. J. Wang, Z. Zhang, and X. Luo. 2012. Intragraft CD11b (+) IDO (+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions. Am. J. Transplant. 12:2920-2929.
9. Ochando, J. C., and S. H. Chen. 2012. Myeloid-derived suppressor cells in transplantation and cancer. Immunol. Res. 54:275-285.
10. Garcia, M. R., L. Ledgerwood, Y. Yang, J. Xu, G. Lal, B. Burrell, G. Ma, D. Hashimoto, Y. Li, P. Boros, et al. 2010. Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J. Clin. Invest. 120:2486-2496.
11. Wu, T., C. Sun, Z. Chen, Y. Zhen, J. Peng, Z. Qi, X. Yang, and Y. Zhao. 2012. Smad3-deficient CD11b (+) Gr1 (+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway. J. Immunol. 189:4989-5000.
12. Movahedi, K., M. Guilliams, J. Van Den Bossche, R. Van Den Bergh, C. Gysemans, A. Beschin, P. De Baetselier, and J. A. Van Ginderachter. 2008. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111:4233-4244.
13. Ostrand-Rosenberg, S., and P. Sinha. 2009. Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182:4499-4506.
14. Bak, S. P., A. Alonso, M. J. Turk, and B. Berwin. 2008. Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression. Mol. Immunol. 46:258-268.
15. Watanabe, S., K. Deguchi, R. Zheng, H. Tamai, L. X. Wang, P. A. Cohen, and S. Shu. 2008. Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J. Immunol. 181:3291-3300.
16. Hoechst, B., L. A. Ormandy, M. Ballmaier, F. Lehner, C. Krüger, M. P. Manns, T. F. Greten, and F. Korangy. 2008. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4 (+) CD25 (+) Foxp3 (+) T cells. Gastroenterology 135:234-243.
17. Huang, B., P. Y. Pan, Q. Li, A. I. Sato, D. E. Levy, J. Bromberg, C. M. Divino, and S. H. Chen. 2006. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66:1123-1131.
18. Mazzoni, A., V. Bronte, A. Visintin, J. H. Spitzer, E. Apolloni, P. Serafini, P. Zanovello, and D. M. Segal. 2002. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 168:689-695.
19. Brok, H. P., J. M. Vossen, and P. J. Heidt. 1998. IFN-gamma-mediated prevention of graft-versus-host disease: pharmacodynamic studies and influence on proliferative capacity of chimeric spleen cells. Bone Marrow Transplant. 22:1005-1010.
20. Brok, H. P., J. M. Vossen, and P. J. Heidt. 1997. Interferon-gamma- mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice. Bone Marrow Transplant. 19:601-606.
21. Sun, X., Z. J. Gong, Z. W. Wang, T. Li, J. Y. Zhang, H. C. Sun, S. Liu, L. Huang, C. Huang, and Z. H. Peng. 2012. IDO-competent-DCs induced by IFN-γ attenuate acute rejection in rat liver transplantation. J. Clin. Immunol. 32:837-847.
22. Ravishankar, B., and T. L. McGaha. 2013. O death where is thy sting? Immunologic tolerance to apoptotic self. Cell. Mol. Life Sci. 70:3571-3589.
23. Matsumura, T., M. Ato, T. Ikebe, M. Ohnishi, H. Watanabe, and K. Kobayashi. 2012. Interferon-γ-producing immature myeloid cells confer protection against severe invasive group A Streptococcus infections. Nat. Commun. 3:678.
24. Zhang, Z., L. Zhu, D. Quan, B. Garcia, N. Ozcay, J. Duff, C. Stiller, A. Lazarovits, D. Grant, and R. Zhong. 1996. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 62:1267-1272.
25. Daley, J. M., A. A. Thomay, M. D. Connolly, J. S. Reichner, and J. E. Albina. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83:64-70.
26. Pruijt, J. F., P. Verzaal, R. Van Os, E. J. De Kruijf, M. L. Van Schie, A. Mantovani, A. Vecchi, I. J. Lindley, R. Willemze, S. Starckx, et al. 2002. Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. Proc. Natl. Acad. Sci. USA 99:6228-6233.
27. Wojtasiak, M., D. L. Pickett, M. D. Tate, S. L. Londrigan, S. Bedoui, A. G. Brooks, and P. C. Reading. 2010. Depletion of Gr-1+, but not Ly6G+, immune cells exacerbates virus replication and disease in an intranasal model of herpes simplex virus type 1 infection. J. Gen. Virol. 91:2158-2166.
28. Youn, J. I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181:5791-5802.
29. Sinha, P., V. K. Clements, S. K. Bunt, S. M. Albelda, and S. Ostrand-Rosenberg. 2007. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 179:977-983.
30. Hwu, P., M. X. Du, R. Lapointe, M. Do, M. W. Taylor, and H. A. Young. 2000. Indoleamine 2, 3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164:3596-3599.
31. Solito, S., V. Bronte, and S. Mandruzzato. 2011. Antigen specificity of immune suppression by myeloid-derived suppressor cells. J. Leukoc. Biol. 90:31-36.
32. Yang, W. C., G. Ma, S. H. Chen, and P. Y. Pan. 2013. Polarization and reprogramming of myeloid-derived suppressor cells. J. Mol. Cell Biol. 5:207-209.
33. Pillay, J., T. Tak, V. M. Kamp, and L. Koenderman. 2013. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cell. Mol. Life Sci. 70:3813-3827.
34. Fridlender, Z. G., J. Sun, I. Mishalian, S. Singhal, G. Cheng, V. Kapoor, W. Horng, G. Fridlender, R. Bayuh, G. S. Worthen, and S. M. Albelda. 2012. Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloidderived suppressor cells and normal neutrophils. PLoS One 7:e31524.
35. Fridlender, Z. G., J. Sun, S. Kim, V. Kapoor, G. Cheng, L. Ling, G. S. Worthen, and S. M. Albelda. 2009. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 16:183-194.
36. Ellis, T. N., and B. L. Beaman. 2002. Murine polymorphonuclear neutrophils produce interferon-gamma in response to pulmonary infection with Nocardia asteroides. J. Leukoc. Biol. 72:373-381.
37. Kirby, A. C., U. Yrlid, and M. J. Wick. 2002. The innate immune response differs in primary and secondary Salmonella infection. J. Immunol. 169:4450-4459.
38. Goñi, O., P. Alcaide, and M. Fresno. 2002. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1 (+)) CD11b (+) immature myeloid suppressor cells. Int. Immunol. 14:1125-1134.
39. Medeiros, A. I., C. H. Serezani, S. P. Lee, and M. Peters-Golden. 2009. Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling. J. Exp. Med. 206:61-68.
40. Yu, J., W. Du, F. Yan, Y. Wang, H. Li, S. Cao, W. Yu, C. Shen, J. Liu, and X. Ren. 2013. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. J. Immunol. 190:3783-3797.
41. Zhang, H., I. Maric, M. J. Di Prima, J. Khan, R. J. Orentas, R. N. Kaplan, and C. L. Mackall. 2013. Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood 122:1105-1113.
42. Mougiakakos, D., R. Jitschin, L. Von Bahr, I. Poschke, R. Gary, B. Sundberg, A. Gerbitz, P. Ljungman, and K. Le Blanc. 2013. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation. Leukemia 27:377-388.
43. Bunt, S. K., P. Sinha, V. K. Clements, J. Leips, and S. Ostrand-Rosenberg. 2006. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol. 176:284-290.
44. Nagaraj, S., K. Gupta, V. Pisarev, L. Kinarsky, S. Sherman, L. Kang, D. L. Herber, J. Schneck, and D. I. Gabrilovich. 2007. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat. Med. 13:828-835.
45. Reichert, T. E., L. Strauss, E. M. Wagner, W. Gooding, and T. L. Whiteside. 2002. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Clin. Cancer Res. 8:3137-3145.
46. Corzo, C. A., T. Condamine, L. Lu, M. J. Cotter, J. I. Youn, P. Cheng, H. I. Cho, E. Celis, D. G. Quiceno, T. Padhya, et al. 2010. HIF-1a regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207:2439-2453.
47. Rosborough, B. R., D. Raich-Regue, H. R. Turnquist, and A. W. Thomson. 2014. Regulatory myeloid cells in transplantation. Transplantation 97:367-379